Tag: veterinary biologics market insights

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

2024-2033 Veterinary Biologics Market: What Growth Rate is Predicted?

The market size for veterinary biologics has experienced significant expansion in recent times. The market is projected to increase from $11.77 billion in 2023 to $12.78 billion in 2024, advancing at a compound annual growth rate (CAGR) of 8.6%. Factors like animal disease epidemics, regulatory assistance and guidelines, the requirement for safe food, trade globalization, and the economic importance of livestock have contributed to the growth during the historical period.

The projected size of the veterinary biologics market is anticipated to experience significant growth in the coming years. It is likely to expand to $17.11 billion in 2028, with a compound annual growth rate (CAGR) of 7.6%. Causes for growth during the projected period include the emergence of infectious diseases, alterations in climate and disease patterns, precision in livestock farming, a unifying health approach, and an upsurge in pet ownership. Foreseen trends for this period comprise education and training initiatives, environment-friendly and sustainable biologics, incorporation of digital health records, growth in companion animal biologics, as well as personalized and targeted treatments.

Claim Your Free Sample of the Global Veterinary Biologics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

What Aspects Are Driving the Expansion of the veterinary biologics Market?

An upsurge in animal diseases is anticipated to spur the expansion of the veterinary biologics market. Animal diseases, implying health conditions that impinge various animal species, are on the rise. This surge necessitates improved diagnosis and treatment that can be facilitated using veterinary biologics, employing immunological means to cure animal afflictions. For example, the European Center for Disease Prevention and Control, a Sweden-based health body of the European Union, reported in October 2022 that a whopping 2,467 avian influenza outbreaks were observed in poultry, impacting 48 million birds. Additionally, 187 instances were identified in captive birds. Moreover, figures from the World Health Organization, a specialized Switzerland-based agency of the United Nations in July 2022, attest that rabies results in 59,000 human fatalities annually in over 150 countries, with a staggering 95% of cases being reported in Africa and Asia. Hence, the escalating incidents of animal diseases are fuelling the growth of veterinary biologics.

What Are the Significant Segments of the Veterinary Biologics Market?

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

What Trends Are Influencing the Evolution of the Veterinary Biologics Market?

The crafting of new biologics is an emerging trend witnessing increased traction in the veterinary biologics landscape. To stay ahead in the market, renowned companies in the veterinary biologics industry are innovating and producing unique biologics. An apt example of this is the March 2021 launch by US-based Elanco Animal Health Incorporated, a veterinary pharmaceutical firm, of Elura (capromorelin oral solution) specifically to address weight loss issues in felines with chronic kidney diseases (CKD). This debut drug is unprecedented in being a ghrelin receptor agonist endorsed by the US Food and Drug Administration, an American health regulation body. It leverages a novel mode of action to effectively deal with weight loss problems in cats grappling with CKD. The drug, which is a palatable oral solution that comes in a modest dosage, can be administered for prolonged periods and can be started off at the diagnosis stage to help pet owners better handle the conditions of their pets throughout the duration of the sickness.

Order Now for Fast Delivery of Your Veterinary Biologics Market Report!

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Geographic Areas Are Influencing the Growth of the Veterinary Biologics Market?

North America was the largest region in the veterinary biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Veterinary Biologics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the veterinary biologics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Veterinary Biologics Market Include

1. Veterinary Biologics Market Executive Summary

2. Veterinary Biologics Market Segments

3. Veterinary Biologics Market Size And Template Market Growth Rate

4. Key Veterinary Biologics Market Trends

5. Major Veterinary Biologics Market Drivers

……

25. Key Mergers And Acquisitions In The Veterinary Biologics Market

26. Top Veterinary Biologics Companies

27. Veterinary Biologics Market Opportunities And Strategies

28. Veterinary Biologics Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Veterinary Laboratory Testing Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-laboratory-testing-services-global-market-report

Veterinary Hematology Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Animal Hospitals And Veterinary Clinics Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/animal-hospitals-and-veterinary-clinics-market

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The veterinary biologics market has witnessed robust growth in recent years, with the market size expanding from $11.77 billion in 2023 to $12.78 billion in 2024, showcasing a compound annual growth rate (CAGR) of 8.6%. This remarkable surge is attributed to several key factors:

• Animal Disease Outbreaks: The rise in the prevalence of animal diseases has been a significant driver, necessitating better diagnosis and treatment methods.
• Regulatory Support and Standards: Stringent regulations and standards have fostered the demand for safe and effective veterinary biologics.
• Globalization of Trade: With globalization, there’s an increased need for ensuring the safety and health of animals in the global trade of livestock and animal products.
• Economic Significance of Livestock: Livestock plays a vital role in the economy, driving the demand for veterinary biologics to maintain the health and productivity of these animals.

Future Outlook: Growth Projections

The growth momentum of the veterinary biologics market is projected to continue in the coming years, with expectations to reach $17.11 billion in 2028, reflecting a CAGR of 7.6%. Key factors contributing to this growth include:

• Emerging Infectious Diseases: The emergence of new diseases necessitates the development of innovative biologics for prevention and treatment.
• Climate Change and Disease Patterns: Changing climate conditions influence disease patterns, driving the need for adaptable biologics.
• Precision Livestock Farming: Precision farming techniques require tailored solutions for disease prevention and management.
• One Health Approach: The holistic approach to human, animal, and environmental health emphasizes the need for effective veterinary biologics.
• Increased Pet Ownership Trends: Growing pet ownership fosters demand for biologics catering to companion animals.

Read More On The Veterinary Biologics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Surging Prevalence Of Animal Diseases Sparks Growth In The Veterinary Biologics Market

Responding to the Epidemic

The rise in animal diseases has become a critical concern globally, necessitating proactive measures for containment and treatment. Notable instances include:

• Avian Influenza Outbreaks: In 2022, numerous avian influenza outbreaks were reported, underscoring the need for effective disease management strategies.
• Rabies Epidemic: Rabies continues to pose a significant threat, particularly in Africa and Asia, highlighting the importance of preventive measures.

Industry Landscape and Major Players

Leading companies operating in the veterinary biologics market include Bayer AG, Zoetis Inc., Merck Animal Health Inc., and Elanco Animal Health. These entities play a pivotal role in driving innovation and product development to address the growing demand for veterinary biologics.

Advancements In Veterinary Biologics Market Through Novel Approaches In Treating Chronic Conditions

Pioneering Innovations

The development of novel biologics stands as a prominent trend in the veterinary biologics market, with companies striving to introduce innovative solutions to address chronic conditions. Noteworthy developments include:

• Elura for Chronic Kidney Disease in Cats: Elanco Animal Health introduced Elura, a groundbreaking solution for treating weight loss in cats with chronic kidney disease, showcasing the industry’s commitment to pioneering treatments.

Elanco Expands Veterinary Portfolio With Acquisition Of Kindred Biosciences In Strategic Move To Strengthen Dermatology Market Presence

Strategic Expansion

Elanco Animal Health’s acquisition of Kindred Biosciences signifies a strategic move to bolster its position in the dermatology market. By integrating Kindred Biosciences’ expertise and portfolio, Elanco aims to enhance its service offerings and cater to a broader customer base.

Segmentation and Regional Analysis

Segmentation Breakdown

The veterinary biologics market is segmented based on product type, disease type, distribution channel, and application, offering a comprehensive overview of the market dynamics and opportunities.

Regional Dynamics

While North America dominated the veterinary biologics market in 2023, Asia-Pacific is poised to emerge as the fastest-growing region in the forecast period, driven by evolving regulatory landscapes and the increasing focus on animal health.

In conclusion, the veterinary biologics market continues to evolve, propelled by the escalating prevalence of animal diseases and the industry’s commitment to innovation. As stakeholders navigate these dynamic landscapes, strategic collaborations, technological advancements, and a focus on sustainability will be pivotal in shaping the future trajectory of this burgeoning market.

Request for A Sample Of The Global Veterinary Biologics Market Report:

https://www.thebusinessresearchcompany.com/sample_request?id=12366&type=smp